Cyteal Topical Solution
Chlorhexidine digluconate (20%w/v), Chlorocresol, Hexamidine di-isethionate
Combination
PIERRE FABRE MEDICAMENT LABORATORIES
| Pack size | 500ml Squeeze Bottle |
|---|---|
| Dispensing mode | P |
| Source | FRANCE |
| Agent | ALPHAMED CO. (AUH) LTD. |
| Retail Price | AED |
Available as:
Indications
Cyteal Topical Solution is used for:
For reduction of pocket depth in patients with adult periodontitis, used as an adjunct to scaling and root planing procedures. Also for prevention of dental caries, oropharyngeal decontamination in critically ill patients, hand hygiene in health-care personnel, general skin cleanser, and catheter site preparation and care.
Adult Dose
Child Dose
Renal Dose
Administration
Contra Indications
Precautions
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Chlorhexidine digluconate (20%w/v), Chlorocresol, Hexamidine di-isethionate :
Mechanism of Action
Chlorhexidine's antimicrobial effects are associated with the attractions between chlorhexidine (cation) and negatively charged bacterial cells. After chlorhexidine is absorpted onto the organism's cell wall, it disrupts the integrity of the cell membrane and causes the leakage of intracellular components of the organisms.
Note
Cyteal Combination Topical Solution manufactured by PIERRE FABRE MEDICAMENT LABORATORIES. Its generic name is Chlorhexidine digluconate (20%w/v), Chlorocresol, Hexamidine di-isethionate. Cyteal is availble in United Arab Emirates.
Farmaco UAE drug index information on Cyteal Topical Solution is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.